Incannex Healthcare company info

What does Incannex Healthcare do?
Incannex Healthcare ADR (ASX:IHL), (NASDAQ:IXHL) is a dynamic biopharmaceutical company focused on the development of innovative medical treatments. Addressing a wide range of unmet medical needs, Incannex's operations encompass research and development projects aimed at creating therapies in the fields of obstructive sleep apnea, traumatic brain injury, rheumatoid arthritis, and inflammatory lung diseases, among others. The company's objectives are rooted in advancing these projects through clinical trials, leveraging a blend of proprietary drug formulations and novel therapeutic approaches to improve patient outcomes. Incannex Healthcare is committed to navigating the complex regulatory pathways to bring their therapies from the lab to the global market, endeavoring to make a significant impact on healthcare and patient well-being.
Incannex Healthcare  company media
Company Snapshot

Is Incannex Healthcare a public or private company?

key
Ownership
Public

How many people does Incannex Healthcare employ?

people
Employees
15

What sector is Incannex Healthcare in?

pie chart
Sector
Health Care

Where is the head office for Incannex Healthcare ?

location pin
Head Office
Melbourne, Australia

What year was Incannex Healthcare founded?

founded flag
Year Founded
2001
What does Incannex Healthcare specialise in?
/Medical Cannabis /Clinical Trials /Pharmaceutical Development /Respiratory Medicine /Cannabinoid Therapeutics /Neurological Disorders

What are the products and/or services of Incannex Healthcare ?

Overview of Incannex Healthcare offerings
Development of cannabinoid-based therapies for obstructive sleep apnea.
Clinical trials for a treatment aimed at reducing lung inflammation in patients with COVID-19.
Research into psychedelic compounds for mental health conditions.
Innovation of therapies targeting traumatic brain injury and concussion.
Development of anti-inflammatory treatments for chronic obstructive pulmonary disease.
Creating cannabinoid formulations for pain management.

Who is in the executive team of Incannex Healthcare ?

Incannex Healthcare leadership team
  • Mr. Joel Bradley Latham
    Mr. Joel Bradley Latham
    MD, CEO & Executive Director
  • Mr. Lekhram  Changoer M.Sc.
    Mr. Lekhram Changoer M.Sc.
    Chief Technical Officer
  • Mr. Joseph  Swan
    Mr. Joseph Swan
    CFO, Treasurer & Secretary
  • Dr. Mark  Bleackley
    Dr. Mark Bleackley
    Chief Scientific Officer, Head of Programs & Member of the Advisory Board
  • Mr. John  Michailidis B.Sc., EMBA, M.A.I.C.D.
    Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.
    Chief Executive Officer of IncannexTM
  • Ms. Rosemarie  Walsh
    Ms. Rosemarie Walsh
    VP of Clinical Operations & Member of the Advisory Board